<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://wellnesswirekansas.com/article/905790975-allogene-therapeutics-announces-pricing-of-public-offering-of-common-stock</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-15T01:50:00+00:00</news:publication_date>
        <news:title>Allogene Therapeutics Announces Pricing of Public Offering of Common Stock</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905790950-american-addiction-centers-and-filmmaker-jeffrey-shulman-team-up-to-promote-powerful-new-film-on-addiction-and-recovery-with-national-theatrical-tour</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-15T01:17:26+00:00</news:publication_date>
        <news:title>American Addiction Centers and Filmmaker Jeffrey Shulman Team Up to Promote Powerful New Film on Addiction and Recovery with National Theatrical Tour</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1cd36806-58ee-4d6f-935f-bd2088746d5d/medium/what-it-takes-official-film-poster.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905790908-arc-trt-launches-new-website-to-help-uk-men-access-personalised-testosterone-replacement-therapy</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-15T01:03:33+00:00</news:publication_date>
        <news:title>Arc TRT Launches New Website to Help UK Men Access Personalised Testosterone Replacement Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/adfa345c-868c-4bca-bdda-15d2ab4d6315/small/arc-trt-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905791055-epimab-biotherapeutics-to-present-a-novel-prodrug-t-cell-engager-protce-platform-at-the-2026-american-association-for-cancer-research-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-15T01:00:00+00:00</news:publication_date>
        <news:title>EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fa1bd13e-e49a-4b2c-a742-85957a03ad87/small/epimab-logo-for-notified-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905776369-mesoblast-acquires-chimeric-antigen-receptor-car-platform-technology-for-precision-enhanced-cell-products</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-15T00:10:56+00:00</news:publication_date>
        <news:title>Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905776367-telix-doses-first-patient-in-phase-3-ipax-bright-trial-of-tlx101-tx-for-recurrent-glioblastoma</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T23:04:43+00:00</news:publication_date>
        <news:title>Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905763136-bruno-mars-presents-1-million-gift-to-intermountain-health-for-the-future-nevada-children-s-hospital</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T21:40:23+00:00</news:publication_date>
        <news:title>Bruno Mars Presents $1 Million Gift to Intermountain Health for the Future Nevada Children’s Hospital</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OGZmZTRlNzItNGMwOS00NDY4LWJlNzgtZGRiNjk5Mjc4ODU1LTEyNjkxMjYtMjAyNi0wNC0xNC1lbg==/tiny/Intermountain-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905763051-lymph-tonic-claims-evaluated-the-forbidden-enzyme-protocol-for-safe-weight-loss-support-by-lymphtonic</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T21:37:48+00:00</news:publication_date>
        <news:title>Lymph Tonic Claims Evaluated: The Forbidden Enzyme Protocol for Safe Weight Loss Support by LymphTonic</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Lymph-Tonic.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905762991-enlitic-announces-ensight-2-2-a-breakthrough-in-imaging-data-standardization</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T21:29:27+00:00</news:publication_date>
        <news:title>Enlitic Announces Ensight 2.2, a Breakthrough in Imaging Data Standardization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/372da620-5254-4763-8d1e-53195694c648/medium/enlitic-announces-ensight-2-2-a-breakthrough-in-imaging-data.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905750683-lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:54:05+00:00</news:publication_date>
        <news:title>LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905749724-ankalax-claims-evaluated-effective-ankle-massager-brace-with-heat-therapy-vibration-compression-for-recovery</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:28:01+00:00</news:publication_date>
        <news:title>Ankalax Claims Evaluated: Effective Ankle Massager Brace with Heat Therapy + Vibration Compression for Recovery</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Ankalax-Ankle-Massage-Brace.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905749617-update-r1-announces-phare-os-expansion-to-help-providers-navigate-growing-complexity-and-margin-pressure</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:25:34+00:00</news:publication_date>
        <news:title>UPDATE - R1 Announces Phare OS Expansion to Help Providers Navigate Growing Complexity and Margin Pressure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/728189a4-e254-443f-8452-315403fd70f4/small/r1-logo-black-25-947x676-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905748202-heartsciences-reminds-its-shareholders-to-submit-their-vote-at-the-upcoming-april-30-2026-annual-shareholders-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:15:00+00:00</news:publication_date>
        <news:title>HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/800a6aae-74f3-42bb-9199-5e169ed9b881/small/heartsciences-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905748222-aligos-therapeutics-announces-first-interim-analysis-results-from-the-phase-2-b-supreme-study-of-pevifoscorvir-sodium-in-participants-with-chronic</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:05:00+00:00</news:publication_date>
        <news:title>Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905748406-structure-therapeutics-appoints-matthew-lang-j-d-as-chief-operating-officer-and-general-counsel</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:05:00+00:00</news:publication_date>
        <news:title>Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/154be1d7-62d7-4688-be20-3b2a10a2628e/small/structure-therapeutics-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905748488-geron-corporation-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:05:00+00:00</news:publication_date>
        <news:title>Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905748979-canadian-animal-health-institute-unleashes-cutest-pets-on-parliament-hill</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:00:00+00:00</news:publication_date>
        <news:title>Canadian Animal Health Institute Unleashes Cutest Pets on Parliament Hill </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/197c2953-84e0-435d-8524-c68da19d27e9/small/cahi-logo-jpg.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905748980-l-institut-canadien-de-la-sant-animale-lib-re-les-animaux-de-compagnie-les-plus-mignons-sur-la-colline-du-parlement</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T20:00:00+00:00</news:publication_date>
        <news:title>L’Institut canadien de la santé animale libère les animaux de compagnie les plus mignons sur la Colline du Parlement </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/197c2953-84e0-435d-8524-c68da19d27e9/small/cahi-logo-jpg.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905736235-national-roundtable-advances-women-s-health-and-chronic-pain-research-in-canada</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T19:17:30+00:00</news:publication_date>
        <news:title>National Roundtable Advances Women’s Health and Chronic Pain Research in Canada</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/32c18902-bbfd-4447-afb8-37712906af67/small/centre-of-excellence-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905736758-la-table-ronde-nationale-fait-progresser-les-recherches-sur-la-sant-et-la-douleur-chronique-au-canada</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T19:17:30+00:00</news:publication_date>
        <news:title>La table ronde nationale fait progresser les recherches sur la santé et la douleur chronique au Canada</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/32c18902-bbfd-4447-afb8-37712906af67/small/centre-of-excellence-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905736407-dr-eric-haeger-establishes-new-scholarship-program-to-support-future-medical-professionals-and-healthcare-innovation</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T19:07:19+00:00</news:publication_date>
        <news:title>Dr. Eric Haeger Establishes New Scholarship Program to Support Future Medical Professionals and Healthcare Innovation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/46ed0337-1c54-4d9f-b03a-6578ae568fc8/medium/dr-eric-haeger-scholarship.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905735070-adcare-hospital-hosts-eagle-scout-led-initiative-to-support-patients-in-recovery</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T18:45:00+00:00</news:publication_date>
        <news:title>AdCare Hospital Hosts Eagle Scout-Led Initiative to Support Patients in Recovery</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d233fb10-552e-4814-b746-a0797cce4b93/small/logo-adcare-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905735131-exit-156-capital-and-nightware-announce-strategic-investment-partnership</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T18:33:00+00:00</news:publication_date>
        <news:title>EXIT 156 CAPITAL AND NIGHTWARE ANNOUNCE STRATEGIC INVESTMENT PARTNERSHIP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a6f5b4f9-8819-48df-bbb5-58f7d222ab16/small/nightware-inc-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905734763-microbot-medical-to-highlight-commercial-achievements-leading-to-the-full-market-release-fmr-of-the-liberty-endovascular-robotic-system-at-the</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T18:30:00+00:00</news:publication_date>
        <news:title>Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905735393-supporting-women-s-health-can-unlock-workforce-potential-here-s-what-employers-and-allies-can-do</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T18:24:12+00:00</news:publication_date>
        <news:title>Supporting Women’s Health Can Unlock Workforce Potential. Here’s What Employers and Allies Can Do</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/669af2b2-a5eb-433a-b6da-54ef95a7977b/small/whcc-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905735430-le-soutien-la-sant-des-femmes-maximise-le-potentiel-de-la-main-d-uvre-voici-comment-les-employeurs-et-les-alli-s-peuvent-aider</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T18:24:12+00:00</news:publication_date>
        <news:title>Le soutien à la santé des femmes maximise le potentiel de la main-d’œuvre. Voici comment les employeurs et les alliés peuvent aider</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/669af2b2-a5eb-433a-b6da-54ef95a7977b/small/whcc-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905735110-scripps-encinitas-named-among-top-100-hospitals-in-the-u-s</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T18:17:15+00:00</news:publication_date>
        <news:title>Scripps Encinitas Named Among Top 100 Hospitals in the U.S.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Y2Q0NWE4NGUtZjcyNi00NDM4LWJjMDQtNGRiYWE5MGJkODI4LTExMDA0OTEtMjAyNi0wNC0xNC1lbg==/tiny/Scripps-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905735261-galera-therapeutics-and-obsidian-therapeutics-announce-merger-agreement-and-350-million-concurrent-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T18:08:10+00:00</news:publication_date>
        <news:title>Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d4232a7c-0097-427f-af68-18288ab26fa6/small/galera-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905721688-excellent-brain-ltd-launches-new-android-version-for-neurofeedback-for-adhd-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T17:29:00+00:00</news:publication_date>
        <news:title>Excellent Brain Ltd. Launches New Android Version for Neurofeedback for ADHD Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3230185/WhatsApp-Image-2026-04-05-at-12.59.39.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905721597-van-nuys-premier-rehabilitation-center-injury-docs-celebrates-10-000th-patient</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T16:37:00+00:00</news:publication_date>
        <news:title>Van Nuys&#39; Premier Rehabilitation Center, Injury Docs, Celebrates 10,000th Patient</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3228271/SCR-20260410-mizp.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905707675-ose-immunotherapeutics-evolves-its-leadership-team</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T16:00:00+00:00</news:publication_date>
        <news:title>OSE Immunotherapeutics Evolves its Leadership Team </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905707763-ose-immunotherapeutics-fait-voluer-son-quipe-de-direction</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T16:00:00+00:00</news:publication_date>
        <news:title>OSE Immunotherapeutics fait évoluer son équipe de direction</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905708063-comprehensive-healthcare-launches-just-in-time-prescriber-scheduling-to-improve-access-to-behavioral-health-medication-services</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T16:00:00+00:00</news:publication_date>
        <news:title>Comprehensive Healthcare Launches “Just In Time” Prescriber Scheduling to Improve Access to Behavioral Health Medication Services</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87b3c91d-8292-48c4-aaff-e3ee4e518ee3/small/ch-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905708364-providence-saint-john-s-health-center-announces-largest-philanthropic-gift-in-its-history-through-transformative-stan-lucas-legacy</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T16:00:00+00:00</news:publication_date>
        <news:title>Providence Saint John’s Health Center Announces Largest Philanthropic Gift in Its History Through Transformative Stan Lucas Legacy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5cec38c7-016b-458b-b0cf-462a36e4f605/small/saintjohnshealthcenter-2l-clr-4cp-lowerres-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905708957-ascellahealth-inaugurates-strategic-advisory-council-with-founding-members-advances-pharmacy-benefits-ecosystem-through-technology-deployment-and</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T15:30:00+00:00</news:publication_date>
        <news:title>AscellaHealth Inaugurates Strategic Advisory Council, With Founding Members, Advances Pharmacy Benefits Ecosystem Through Technology Deployment and Specialty Expertise</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5278c55f-330c-41a1-8446-d8b1a07bbc55/small/ah-logo-colornotag-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905699380-vietnam-shocks-the-world-with-animal-to-human-organ-transplantation-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T14:56:25+00:00</news:publication_date>
        <news:title>Vietnam Shocks the World With Animal-To-Human Organ Transplantation Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8986a8b7-9a74-40ca-bd2f-eef76084e773/medium/vgct-s-source.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905695842-major-shareholder-announcement</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T14:44:22+00:00</news:publication_date>
        <news:title>Major Shareholder Announcement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905697702-advanced-radiation-centers-of-new-york-launches-softray-therapy-offering-new-non-surgical-relief-of-inflammatory-tendon-and-arthritis-pain</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T14:04:00+00:00</news:publication_date>
        <news:title>Advanced Radiation Centers of New York Launches SoftRay™ Therapy, Offering New Non-Surgical Relief of Inflammatory, Tendon and Arthritis Pain</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/de310bc0-7bc1-48f5-b455-ca8f8ffd0472/medium/softray-therapy-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905695461-zealand-pharma-appoints-eric-rojas-as-vice-president-and-head-of-investor-relations</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T14:00:00+00:00</news:publication_date>
        <news:title>Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/b505bacc-6953-4eb4-ab25-e03008f97b92/medium/eric-rojas.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905696037-award-winning-medical-alert-system-bay-alarm-medical-launches-caregiver-sos-youtube-series-to-support-family-caregivers</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T14:00:00+00:00</news:publication_date>
        <news:title>Award-winning Medical Alert System Bay Alarm Medical Launches &#39;Caregiver SOS&#39; YouTube Series to Support Family Caregivers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3140430/Screenshot-2026-03-06-at-12.32.15%E2%80%AFPM.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905696490-neion-bio-strengthens-genome-engineering-leadership-with-appointment-of-colossal-biosciences-veteran-james-kehler</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T14:00:00+00:00</news:publication_date>
        <news:title>Neion Bio Strengthens Genome Engineering Leadership with Appointment of Colossal Biosciences Veteran James Kehler</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e37518bc-d9ef-45ce-99a7-35e82f143444/medium/dr-james-kehler.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905696688-reducing-administrative-burden-raises-medicaid-provider-satisfaction-by-50-new-study-finds</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T14:00:00+00:00</news:publication_date>
        <news:title>Reducing Administrative Burden Raises Medicaid Provider Satisfaction by 50%, New Study Finds</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24cdff2f-7c95-4f21-aebb-25c4628d94e7/small/gainwell-logo-suite-061720-logosuite-png-gainwell-logo-150-r.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905697695-hibercell-to-present-preclinical-data-demonstrating-the-enhanced-antitumor-activity-of-hc-7366-in-combination-with-vegfr-tkis-in-clear-cell-renal-cell</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T14:00:00+00:00</news:publication_date>
        <news:title>HiberCell to Present Preclinical Data Demonstrating the Enhanced Antitumor Activity of HC-7366 in Combination with VEGFR-TKIs in Clear Cell Renal Cell Carcinoma (ccRCC)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d168805a-8691-40f2-abcf-fb63a607f112/small/hybercell-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905697837-grand-river-aseptic-manufacturing-announces-100-million-investment-in-sterile-manufacturing-capabilities</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:55:44+00:00</news:publication_date>
        <news:title>Grand River Aseptic Manufacturing Announces $100 Million Investment in Sterile Manufacturing Capabilities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OTBkMmRlZDktNGMxYi00Mjk1LWE0YWMtZTBhYjhlOTMyMTFhLTUwMDE1MTE4Ny0yMDI2LTA0LTE0LWVu/tiny/Grand-River-Aseptic-Manufactur.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905697955-penn-highlands-healthcare-addresses-community-needs</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:44:34+00:00</news:publication_date>
        <news:title>Penn Highlands Healthcare Addresses Community Needs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZGEyZjE1ZWMtZDA4MC00MmM1LWI0ZmQtNmVlMTM5ODUxMDgzLTEyNTYxMzgtMjAyNi0wNC0xNC1lbg==/tiny/Penn-Highlands-Healthcare.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905686836-culture-biosciences-announces-strategic-addition-to-its-board-of-directors-to-accelerate-hardware-commercialization-and-saas-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:30:00+00:00</news:publication_date>
        <news:title>Culture Biosciences Announces Strategic Addition to Its Board of Directors to Accelerate Hardware Commercialization and SaaS Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ce8c1148-eecd-40b0-b1b7-f858ab8c3c4f/small/culture-logo-one-color-rgb-1500px-300ppi-1-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905685691-virtuix-delivers-omni-one-to-florida-gulf-coast-university-for-use-in-physical-therapy-and-clinical-simulation</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:15:00+00:00</news:publication_date>
        <news:title>Virtuix Delivers Omni One to Florida Gulf Coast University for Use in Physical Therapy and Clinical Simulation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2ba7d28b-48bc-45db-b49e-929295456dc1/medium/omni-one-at-fgu-s-marieb-college-of-health-and-human-service.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905685932-myriad-genetics-expands-access-for-mychoice-test-to-prostate-cancer-patients-in-japan</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:15:00+00:00</news:publication_date>
        <news:title>Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905685481-nextech-reduces-healthcare-s-payment-reconciliation-burden-with-reimagined-embedded-payment-processing-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:00:00+00:00</news:publication_date>
        <news:title>Nextech Reduces Healthcare’s Payment Reconciliation Burden with Reimagined Embedded Payment Processing Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2b32c79b-9e9d-48d1-ae49-77d47537ae62/small/nextech-logo-jpg-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905685781-alliance-direct-benefits-launches-alliance-complete-as-demand-grows-for-simplified-bundled-support-offerings</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:00:00+00:00</news:publication_date>
        <news:title>Alliance Direct Benefits Launches Alliance Complete as Demand Grows for Simplified, Bundled Support Offerings</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZGM1MDA4YTEtODYzZi00YzgzLThkODAtMjEwNWJhZjU2NjQ2LTUwMDE2MDEwNC0yMDI2LTA0LTE0LWVu/tiny/Alliance-Direct-Benefits.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905686904-healthedge-partners-with-ellipsis-health-to-scale-care-management-through-ai-powered-virtual-nursing</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:00:00+00:00</news:publication_date>
        <news:title>HealthEdge® Partners with Ellipsis Health to Scale Care Management Through AI-Powered Virtual Nursing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/18d2dfaf-8f95-4f15-99e6-ae8282b42123/small/healthedge-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905686993-neomorph-to-highlight-progress-in-targeted-protein-degradation-science-at-the-american-association-for-cancer-research-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:00:00+00:00</news:publication_date>
        <news:title>Neomorph to Highlight Progress in Targeted Protein Degradation Science at the American Association for Cancer Research Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d00180c1-5def-41b6-95c7-018ca5e07565/small/neomorph-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905687330-haystack-health-appoints-digital-health-leader-bill-snyder-as-chief-executive-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:00:00+00:00</news:publication_date>
        <news:title>Haystack Health Appoints Digital Health Leader Bill Snyder as Chief Executive Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f6629b37-d06b-4203-a6cd-f233134c4f32/small/hh-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905687785-merakris-therapeutics-and-ifyber-collaboration-receives-top-sawc-research-award-for-mtx-001-wound-healing-study-in-human-skin-model</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T13:00:00+00:00</news:publication_date>
        <news:title>Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5b9c5fed-3332-4d4d-b8b6-6ab1b15faaed/small/mrks-brand-logo-final-fullcolor-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905685907-just-salad-opens-in-east-amherst-n-y</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:57:00+00:00</news:publication_date>
        <news:title>Just Salad Opens in East Amherst, N.Y.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0bfa206d-0a40-4b13-a05a-267ebef25a6a/medium/just-salad-east-amherst-new-york-storefront.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905688308-entera-bio-to-host-key-opinion-leader-webinar-highlighting-the-osteoporosis-treatment-landscape-and-the-opportunity-for-eb613</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:45:00+00:00</news:publication_date>
        <news:title>Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9b4ae2bf-733d-4180-b48c-d0fa3f26c81a/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905688406-actuate-therapeutics-announces-nature-medicine-publication-of-clinical-trial-results-showing-doubling-of-the-rate-of-survival-with-elraglusib-plus</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:45:00+00:00</news:publication_date>
        <news:title>Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f65ca94c-eff8-4376-ac67-ded1b03b3bcc/small/actuatetx-logo-color300-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905688494-extendicare-announces-closing-of-450-million-inaugural-offering-of-investment-grade-senior-unsecured-notes</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:39:06+00:00</news:publication_date>
        <news:title>Extendicare Announces Closing of $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905686858-cellectar-enrolls-first-patient-in-clr-125-auger-emitting-radioconjugate-phase-1b-clinical-trial-targeting-refractory-triple-negative-breast-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:35:00+00:00</news:publication_date>
        <news:title>Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905686003-pelthos-therapeutics-to-participate-in-piper-sandler-spring-biopharma-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:30:00+00:00</news:publication_date>
        <news:title>Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7d71f2d0-a48f-4fe0-a49c-138de21bc0e1/small/pelthos-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905686896-cytodyn-to-present-at-the-aacr-annual-meeting-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:30:00+00:00</news:publication_date>
        <news:title>CytoDyn to Present at the AACR Annual Meeting 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905687404-clinical-data-supporting-targeted-chemotherapeutic-delivery-via-renovorx-s-tamp-therapy-platform-presented-at-2026-sir-annual-scientific-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:30:00+00:00</news:publication_date>
        <news:title>Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905688178-join-nexalin-s-exclusive-live-investor-webinar-and-q-a-session-on-april-21</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:30:00+00:00</news:publication_date>
        <news:title>Join Nexalin’s Exclusive Live Investor Webinar and Q&amp;A Session on April 21</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905688250-meiragtx-to-present-3-year-data-from-the-phase-1-aquax-clinical-study-of-aav-haqp1-for-the-treatment-of-grade-2-3-radiation-induced-xerostomia-on</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:30:00+00:00</news:publication_date>
        <news:title>MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6b45b8d0-975e-494b-8a46-b88360aa1791/small/mgx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905688290-tomi-reports-strong-q1-2026-sales-of-high-margin-bit-solution-indicating-positive-growth-trends</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:30:00+00:00</news:publication_date>
        <news:title>TOMI Reports Strong Q1 2026 Sales of High-Margin BIT Solution, Indicating Positive Growth Trends</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905687539-biomerica-launches-infoods-ibs-in-canada-through-partnerships-with-phoenix-airmid-biomedical-and-canalt-health-labs</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:19:00+00:00</news:publication_date>
        <news:title>Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905673841-inspira-technologies-appoints-yoav-rozanovich-as-chief-business-officer-to-drive-immediate-revenue-growth-and-quantum-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:01:00+00:00</news:publication_date>
        <news:title>Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905669423-community-routes-access-to-mental-health-care-provides-continued-funding-for-mental-health-services-at-free-charitable-clinics</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free &amp; Charitable Clinics</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905669681-amneal-launches-first-two-respiratory-metered-dose-inhalation-products-in-the-u-s</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905669769-biovie-announces-abstract-accepted-for-presentation-at-the-2026-american-academy-of-neurology-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f437d04b-c089-46eb-bca8-7ef64f68bc9b/small/biovie-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905669779-grace-therapeutics-announces-abstract-highlighting-strive-on-phase-3-trial-results-accepted-for-presentation-at-aan-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c71c0a95-caed-4520-87a9-ac7fefef3f07/small/grce-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905670492-er-kim-signs-exclusive-distribution-agreement-with-leo-pharma-a-s-to-commercialize-loqtorzi-toripalimab-for-nasopharyngeal-and-oesophageal-cancers</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/37d25207-4dc0-4c58-b0cc-d589d363d644/small/erkim-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905670506-hinge-bio-announces-first-subject-dosed-in-phase-1-trial-of-hb2198-a-novel-b-cell-depleting-agent-for-treating-autoimmune-disease</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Hinge Bio Announces First Subject Dosed in Phase 1 Trial of HB2198, a Novel B cell Depleting Agent, for Treating Autoimmune Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/62e1a1c6-154c-4dec-bfb4-79d43b015626/small/hinge-logo-color-2021-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671256-genecentric-to-present-data-on-fragmentomics-based-expressct-liquid-biopsy-technology-at-aacr-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/90d634f2-8dea-4f53-805f-e1e0eaa71133/small/genecentric-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671300-rivus-pharmaceuticals-announces-first-patients-dosed-in-amplify-phase-2-trial-for-hu6-in-mash</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b85bbdee-9fda-4cf2-a14f-d2d608f0b949/small/rivus-pharmaceuticals-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671534-carlsmed-inc-to-report-first-quarter-2026-financial-results-on-may-5-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee16eff2-e0d6-40ca-95c5-4dd84bb4cc5f/small/carlsmed-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671584-nanox-announces-collaboration-with-meir-medical-center-to-deploy-nanox-arc-for-orthopedic-imaging-clinical-study</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Nanox Announces Collaboration with Meir Medical Center to Deploy Nanox.ARC for Orthopedic Imaging Clinical Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2/small/nano-logo-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905672627-corbus-pharmaceuticals-announces-last-patient-first-visit-in-canyon-1-study-of-crb-913-for-the-treatment-for-obesity</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905672678-tempest-appoints-andrew-fang-ph-d-as-head-of-business-development-to-advance-strategic-partnerships-and-global-licensing-efforts</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905672686-genvor-announces-strategic-memorandum-of-understanding-with-canlab-international-to-advance-commercial-peptide-pipeline</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8533fef9-aa8f-43c5-9088-39ab06147641/small/43464-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905672832-real-world-evidence-and-industry-momentum-builds-for-imdx-s-flagship-graftassure-assay</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/418fe8d1-a6a4-4025-84ba-56f14ee83865/small/imdx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905673675-calidi-biotherapeutics-announces-speaker-presentation-at-iovc-conference-in-reykjav-k-iceland-on-april-28th-highlighting-the-redtail-platform-s</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Calidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavík, Iceland on April 28th Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905674131-aclarion-receives-pinnacle-award-for-ai-innovation</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Aclarion Receives Pinnacle Award for AI Innovation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905674226-r1-announces-revenue-performance-solutions-powered-by-phare-os-to-help-providers-navigate-growing-complexity-and-margin-pressure</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>R1 Announces Revenue Performance Solutions Powered by Phare OS to Help Providers Navigate Growing Complexity and Margin Pressure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/728189a4-e254-443f-8452-315403fd70f4/small/r1-logo-black-25-947x676-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905674385-prenetics-im8-health-partners-with-vitamin-angels-to-combat-global-malnutrition-commits-to-impacting-400-000-mothers-and-children-in-year-one</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/106dbe1a-a6e1-49d9-97a2-c5609258bdc7/small/pre-logo-2026-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905674450-clairity-announces-update-to-nccn-guidelines-to-include-ai-mammogram-based-risk-tool-to-identify-future-breast-cancer-risk-in-women-missed-by</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T12:00:00+00:00</news:publication_date>
        <news:title>Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Methods</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0087b812-cef6-4183-8b7c-093385f3bcb5/small/clairitylogo-fullcolor-vertical-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671949-avita-medical-announces-positive-interim-results-from-cohealyx-study-demonstrating-accelerated-time-to-skin-grafting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:45:00+00:00</news:publication_date>
        <news:title>AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905674267-clearmind-medicine-s-cmnd-100-meets-primary-endpoint-in-fda-approved-phase-i-iia-clinical-trial-for-alcohol-use-disorder</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:32:00+00:00</news:publication_date>
        <news:title>Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905670306-sanara-medtech-inc-to-report-first-quarter-2026-financial-results-on-may-12-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:30:00+00:00</news:publication_date>
        <news:title>Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/591eb30b-d3e4-428c-9cd6-536215925b01/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671016-profound-medical-to-participate-in-the-2026-bloom-burton-co-healthcare-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:30:00+00:00</news:publication_date>
        <news:title>Profound Medical to Participate in the 2026 Bloom Burton &amp; Co. Healthcare Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/94d9e057-9de3-430c-9a19-b41ff3e06a1e/small/profound-logo-cmyk-copy-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671585-praxis-precision-medicines-announces-fda-acceptance-of-new-drug-application-for-ulixacaltamide-hcl-in-patients-with-essential-tremor</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:30:00+00:00</news:publication_date>
        <news:title>Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905672048-anavex-life-sciences-highlights-new-scientific-findings-on-shared-biology-between-autism-and-alzheimer-s-disease</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:30:00+00:00</news:publication_date>
        <news:title>Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905674084-medicenna-to-present-at-the-2026-bloom-burton-co-healthcare-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:30:00+00:00</news:publication_date>
        <news:title>Medicenna to Present at the 2026 Bloom Burton &amp; Co. Healthcare Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1644a38b-bed9-4a76-96fa-d57dd028e650/small/medicenna-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905674299-avacta-ceo-christina-coughlin-named-as-one-of-in-vivo-s-2026-rising-leaders</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:26:11+00:00</news:publication_date>
        <news:title>Avacta CEO Christina Coughlin Named as One of In Vivo&#39;s 2026 Rising Leaders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905669756-adagene-adds-industry-veteran-peter-lebowitz-to-scientific-and-strategic-advisory-board</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905669823-trained-therapeutix-discovery-s-chief-scientific-officer-dr-mulder-honored-with-fellowship-at-the-american-institute-for-medical-and-biological</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>Trained Therapeutix Discovery’s Chief Scientific Officer, Dr. Mulder, Honored with Fellowship at the American Institute for Medical and Biological Engineering (AIMBE)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5f6e0329-ec9c-4ab1-9659-d99b938cce16/small/trained-therapeutix-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671051-shopify-to-announce-first-quarter-2026-financial-results-may-5-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>Shopify to Announce First-Quarter 2026 Financial Results May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/28cdf29b-fa48-43e3-a710-ea3ab811a26c/small/shopify-logo-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671069-axogen-inc-to-report-first-quarter-2026-financial-results-on-april-28-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3e4ffe78-2e9a-4972-915e-28c8477c84c1/small/axogen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905671091-vitalhub-announces-novari-health-referral-central-intake-implementation-in-ontario</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>VitalHub Announces Novari Health Referral Central Intake Implementation in Ontario</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905672083-evolveimmune-therapeutics-to-present-update-on-lead-asset-evolve104-and-new-data-for-evolve-t-cell-engager-platform-at-2026-aacr-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/43892ec0-88ad-4f85-b32e-7d049f9ed422/small/evolveimmune-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905673210-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905673892-ligand-partner-travere-therapeutics-receives-full-fda-approval-for-filspari-sparsentan-in-fsgs</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905674161-tiziana-life-sciences-announces-late-breaking-poster-accepted-for-presentation-at-the-7th-world-parkinson-congress</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T11:00:00+00:00</news:publication_date>
        <news:title>Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/991c340c-a083-4bcb-ad41-e7eea83f6f97/small/tiziana-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905658105-genmab-announces-net-sales-of-darzalex-daratumumab-for-first-quarter-of-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T10:22:57+00:00</news:publication_date>
        <news:title>Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905658895-ataibeckley-to-participate-in-upcoming-needham-healthcare-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T10:00:00+00:00</news:publication_date>
        <news:title>AtaiBeckley to Participate in Upcoming Needham Healthcare Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905659602-greenwich-lifesciences-provides-update-on-financing-strategy</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T10:00:00+00:00</news:publication_date>
        <news:title>Greenwich LifeSciences Provides Update on Financing Strategy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905647186-nxera-pharma-s-quviviq-daridorexant-25mg-and-50mg-receives-approval-in-taiwan-for-the-treatment-of-insomnia</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T08:42:59+00:00</news:publication_date>
        <news:title>Nxera Pharma’s QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905636102-mestag-therapeutics-selected-to-present-targeted-ltbr-agonist-mst-0312-in-late-breaking-session-at-aacr-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T07:30:00+00:00</news:publication_date>
        <news:title>Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/d47c1200-a3a8-42b0-b0b9-ffb74568b42c/small/mestag-tx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905636143-asgard-therapeutics-appoints-professor-dr-wolfram-brugger-as-chief-medical-officer-as-it-advances-transformative-personalized-off-the-shelf</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T07:30:00+00:00</news:publication_date>
        <news:title>Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5afbd1fa-9d4b-48d2-8f4f-d262d5a69053/small/asgard-tx-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905614729-panntherapi-annonce-des-avanc-es-majeures-dans-son-d-veloppement-clinique-et-strat-gique</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T06:00:00+00:00</news:publication_date>
        <news:title>PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/79af9499-0fbe-4979-88f5-7c607773acb4/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905614774-renaissance-pharma-limited-an-essential-pharma-company-secures-fda-fast-track-designation-and-ind-clearance-for-daretabart-hu1418k322a-in</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T06:00:00+00:00</news:publication_date>
        <news:title>Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/31276511-f379-4a7a-90b6-af9fc9ac2aa0/small/66795319ca361c8d044a2cc6-essential-pharma-master-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905614817-panntherapi-announces-significant-clinical-development-and-strategic-milestones</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T06:00:00+00:00</news:publication_date>
        <news:title>PannTheraPi Announces Significant Clinical Development and Strategic Milestones</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/79af9499-0fbe-4979-88f5-7c607773acb4/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905614845-kuros-biosciences-reports-51-year-over-year-increase-in-sales-in-the-first-three-months-of-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T05:00:00+00:00</news:publication_date>
        <news:title>Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/ad3777c9-af1f-4b09-a899-3b3d6b8e962d/small/kuros-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905593433-rapid-nutrition-strengthens-capital-markets-infrastructure-with-appointment-of-bowsprit-partners</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T03:00:00+00:00</news:publication_date>
        <news:title>Rapid Nutrition Strengthens Capital Markets Infrastructure with Appointment of Bowsprit Partners</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905574910-elite-force-xl-male-enhancement-gummies-claims-evaluated-effective-men-s-formula-for-steel-power-support</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T01:36:27+00:00</news:publication_date>
        <news:title>Elite Force XL Male Enhancement Gummies Claims Evaluated: Effective Men&#39;s Formula for Steel Power Support</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Elite-Force-XL-Male-Enhancement-Gummies.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905574767-vital-step-glp-1-claims-evaluated-trusted-doctor-prescribed-glp-1-weight-loss-medication-with-no-hidden-fees</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T01:11:21+00:00</news:publication_date>
        <news:title>Vital Step GLP-1 Claims Evaluated: Trusted Doctor-Prescribed GLP-1 Weight Loss Medication with No Hidden Fees</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Vital-Step-GLP-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905565700-gloramd-face-lift-serum-claims-evaluated-liquid-anti-aging-wrinkle-serum-solution-for-skin-renewal</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T00:16:02+00:00</news:publication_date>
        <news:title>GloraMD Face Lift Serum Claims Evaluated: Liquid Anti-Aging Wrinkle Serum Solution for Skin Renewal</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/GloraMD-Face-Lift-Serum.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905557661-biomerica-reports-third-quarter-fiscal-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T22:57:27+00:00</news:publication_date>
        <news:title>Biomerica Reports Third Quarter Fiscal 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905557520-clean-eye-claims-evaluated-the-cleaneye-vision-care-capsules-for-retina-clear-visual-support</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T22:46:54+00:00</news:publication_date>
        <news:title>Clean Eye Claims Evaluated: The CleanEye Vision Care Capsules for Retina Clear Visual Support</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Clean-Eye.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905549775-ballad-health-s-program-for-assisting-uninsured-patients-earns-national-award-for-its-community-based-approach-to-serving-rural-appalachia</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T22:06:57+00:00</news:publication_date>
        <news:title>Ballad Health’s program for assisting uninsured patients earns national award for its community-based approach to serving rural Appalachia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MWQ0YWI3MDEtY2Q2Mi00NDk0LTk5MDAtNTEwNTEyYzRjY2Y5LTExMzUxNTItMjAyNi0wNC0xMy1lbg==/tiny/Ballad-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905549588-aim-immunotech-provides-routine-update-on-annual-filings</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T22:00:00+00:00</news:publication_date>
        <news:title>AIM ImmunoTech Provides Routine Update on Annual Filings</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905542434-xortx-announces-closing-of-acquisition-of-vectus-kidney-anti-fibrotic-asset</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T21:00:00+00:00</news:publication_date>
        <news:title>XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9898c4f8-b373-438a-abfa-709c4372a061/small/xortx-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905542368-spyre-therapeutics-announces-proposed-public-offering-of-its-common-stock</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:46:48+00:00</news:publication_date>
        <news:title>Spyre Therapeutics Announces Proposed Public Offering of its Common Stock</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535759-immucell-bolsters-its-innovation-strategy-with-appointments-of-dr-gilles-guillemette-and-dr-anthony-dimarco-to-the-board-and-moves-to-a-smaller</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:38:05+00:00</news:publication_date>
        <news:title>ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535401-bioage-labs-to-present-at-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:30:00+00:00</news:publication_date>
        <news:title>BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535572-cema-cel-pivotal-trial-interim-data-highlight-strength-of-cellectis-allogeneic-car-t-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:30:00+00:00</news:publication_date>
        <news:title>Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535574-les-donn-es-interm-diaires-de-l-essai-pivot-testant-cema-cel-mettent-en-vidence-la-solidit-de-la-plateforme-car-t-allog-nique-de-cellectis</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:30:00+00:00</news:publication_date>
        <news:title>Les données intermédiaires de l&#39;essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535321-sana-biotechnology-and-mayo-clinic-announce-strategic-collaboration-focused-on-improving-care-in-type-1-diabetes-and-accelerating-development-of-sc451</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:05:00+00:00</news:publication_date>
        <news:title>Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2e5b81be-ddf0-4a60-85f1-3f17c242e8c2/small/sana-biotechnology-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535567-bridgebio-oncology-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:05:00+00:00</news:publication_date>
        <news:title>BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535390-celldex-to-present-at-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:01:00+00:00</news:publication_date>
        <news:title>Celldex to Present at Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535566-revolution-medicines-inc-announces-proposed-offerings-of-common-stock-and-convertible-senior-notes</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:01:00+00:00</news:publication_date>
        <news:title>Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905535570-allogene-therapeutics-announces-proposed-public-offering-of-175-million-of-common-stock</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:01:00+00:00</news:publication_date>
        <news:title>Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905522414-celebrating-national-medical-laboratory-week</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T19:00:00+00:00</news:publication_date>
        <news:title>Celebrating National Medical Laboratory Week</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZWNlYTAwM2UtZDAwNS00MDFjLWJiY2ItZDE4ZTM2YzQyMTM2LTEwOTc1MzMtMjAyNi0wNC0xMy1lbg==/tiny/LifeLabs.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905516650-seer-confirms-receipt-of-unsolicited-proposal-and-director-candidate-nominations-from-radoff-jec-group</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T17:55:00+00:00</news:publication_date>
        <news:title>Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905516710-vital-hemp-gummies-launch-hemp-gummies-australia-nz-or-canada-relieves-anxiety-effective-reduces-pain-relax-stress-with-vital-hemp-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T17:39:33+00:00</news:publication_date>
        <news:title>Vital Hemp Gummies | Launch&quot; Hemp Gummies Australia, NZ Or Canada Relieves Anxiety Effective Reduces Pain Relax Stress With Vital Hemp 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/Resource/Download/3dd4c2ca-9658-477e-9266-ac54964587d8/image1.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905511446-dermatology-devices-market-to-reach-25-6-billion-by-2030-driven-by-rising-skin-cancer-incidence-and-aesthetic-demand</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T17:21:11+00:00</news:publication_date>
        <news:title>Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905511391-ask4sam-nyc-medical-malpractice-attorneys-silberstein-miklos-p-c-expands-focus-on-representing-patients-across-manhattan-brooklyn-and-queens</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T17:05:00+00:00</news:publication_date>
        <news:title>ASK4SAM NYC Medical Malpractice Attorneys Silberstein &amp; Miklos, P.C. Expands Focus on Representing Patients Across Manhattan, Brooklyn and Queens</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3228765/8.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905506130-centre-for-neuro-skills-named-to-newsweek-s-america-s-greatest-midsize-workplaces-in-health-care-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T16:17:00+00:00</news:publication_date>
        <news:title>Centre for Neuro Skills Named to Newsweek’s America’s Greatest Midsize Workplaces in Health Care 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3157a281-770d-4ef2-ade7-353df4ceca6b/medium/image2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905506215-sienna-for-seniors-foundation-1-million-gift-advances-healthy-aging-research-at-ontario-tech-university</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T16:13:38+00:00</news:publication_date>
        <news:title>Sienna for Seniors Foundation $1 Million Gift Advances Healthy Aging Research at Ontario Tech University</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9765702b-cb47-4b36-8255-d86b22ef3df3/medium/ontario-tech-university-and-sienna-senior-living-celebrate-t.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905506159-radical-catheter-technologies-announces-u-s-fda-510-k-clearance-for-its-6f-neurovascular-catheter-broadening-access-across-a-wide-range-of</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T16:05:00+00:00</news:publication_date>
        <news:title>Radical™ Catheter Technologies Announces U.S. FDA 510(k) Clearance for its 6F Neurovascular Catheter -- Broadening Access Across a Wide Range of Applications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5177f2ec-c584-4237-9659-cc7c70377b47/small/radical-catheter-stacked-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905501361-american-kidney-fund-announces-2026-class-of-corporate-members-supporting-work-to-fight-kidney-disease</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T15:37:08+00:00</news:publication_date>
        <news:title>American Kidney Fund Announces 2026 Class of Corporate Members Supporting Work to Fight Kidney Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDkzZjJmMDYtN2I0OC00MTYwLWFlNTItZTBlNDJlMDBmNDk0LTExMDkwNTItMjAyNi0wNC0xMy1lbg==/tiny/American-Kidney-Fund.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905483211-biomx-accelerates-defense-technology-buildout-with-dfsl-acquisition</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T13:20:00+00:00</news:publication_date>
        <news:title>BiomX Accelerates Defense Technology Buildout with DFSL Acquisition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OGZiY2U5N2EtNDEzNS00MjcyLWJiZjUtODViOTA2ZTkxZjdhLTEzMjE4NzEtMjAyNi0wNC0xMy1lbg==/tiny/BiomX.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905482689-polypid-to-present-new-phase-3-shield-ii-data-demonstrating-d-plex-sustained-local-release-at-escmid-global-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T13:15:00+00:00</news:publication_date>
        <news:title>PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6016c990-606d-49e6-a7a8-4d88bace509a/medium/figure-1.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905483265-safespace-global-corporation-announces-operational-expansion-to-support-commercial-deployment-of-its-ai-safety-platform-and-growing-revenue-activities</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T13:15:00+00:00</news:publication_date>
        <news:title>SafeSpace Global Corporation Announces Operational Expansion to Support Commercial Deployment of its AI-safety platform and Growing Revenue Activities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e95639ca-a47d-4c90-a44e-cf8a03b6a6d2/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905482794-switchback-medical-signs-lease-for-18-000-square-foot-facility-in-costa-rica-s-coyol-free-trade-zone</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T13:00:00+00:00</news:publication_date>
        <news:title>Switchback Medical Signs Lease for 18,000 Square Foot Facility in Costa Rica’s Coyol Free Trade Zone</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/de124664-5d20-4955-8016-3dc40767830c/small/switchback-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905482824-switchback-medical-firma-contrato-de-arrendamiento-para-una-instalaci-n-de-18-000-pies-cuadrados-en-la-zona-franca-coyol-de-costa-rica</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T13:00:00+00:00</news:publication_date>
        <news:title>Switchback Medical firma contrato de arrendamiento para una instalación de 18,000 pies cuadrados en la Zona Franca Coyol de Costa Rica</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/de124664-5d20-4955-8016-3dc40767830c/small/switchback-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905482882-neomorph-announces-closing-of-100-million-series-b-financing</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T13:00:00+00:00</news:publication_date>
        <news:title>Neomorph Announces Closing of $100 Million Series B Financing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d00180c1-5def-41b6-95c7-018ca5e07565/small/neomorph-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905482931-senti-biosciences-to-present-on-logic-gated-cell-therapies-in-educational-session-at-aacr-annual-meeting-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T13:00:00+00:00</news:publication_date>
        <news:title>Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/19732ef2-d354-4281-9dc5-6000f190dd83/small/sentibiologo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478607-free-oral-cancer-screenings-in-honor-of-oral-head-and-neck-cancer-awareness-month</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:45:00+00:00</news:publication_date>
        <news:title>Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9472c27c-8b6d-4c87-95fd-31f1f0140263/small/usosm-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478665-xealth-to-facilitate-critical-discussion-among-health-system-executives-on-how-to-maximize-digital-health-value-at-becker-s-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:33:00+00:00</news:publication_date>
        <news:title>Xealth to Facilitate Critical Discussion Among Health System Executives on How to Maximize Digital Health Value at Becker’s Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/33a9b40b-a04e-464b-b15f-f7180c2168ce/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478602-optum-united-healthcare-united-behavioral-health-expands-neurostar-tms-coverage-to-include-psychiatric-mental-health-nurse-practitioners</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:32:00+00:00</news:publication_date>
        <news:title>Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478464-alx-oncology-appoints-jeff-knight-as-chief-development-and-operating-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:30:00+00:00</news:publication_date>
        <news:title>ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478584-oragenics-doses-first-patient-in-phase-iia-clinical-trial-of-onp-002-for-mild-traumatic-brain-injury</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:30:00+00:00</news:publication_date>
        <news:title>Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478638-microbot-medical-commences-full-market-release-fmr-of-the-liberty-endovascular-robotic-system-in-the-u-s-at-the-society-of-interventional</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:30:00+00:00</news:publication_date>
        <news:title>Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478648-heartflow-files-patent-infringement-lawsuit-against-cleerly</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:30:00+00:00</news:publication_date>
        <news:title>Heartflow Files Patent Infringement Lawsuit Against Cleerly</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c6be111e-2f8e-4ac8-8fa8-310dbcbd6e15/small/25-1113-cmyk-hf-logo-positive-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478660-inspira-begins-ame-technology-implementation-process-with-one-of-the-world-s-10-largest-u-s-based-companies</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:16:00+00:00</news:publication_date>
        <news:title>Inspira Begins AME Technology Implementation Process with One of the World&#39;s 10 Largest U.S. Based Companies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905478477-chemed-corporation-announces-a-five-year-450-million-amended-and-restated-credit-agreement</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:15:00+00:00</news:publication_date>
        <news:title>Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1ab951c0-8d76-40e0-bc65-ebeaa1731e66/small/chemed-corp-logo-600x400-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905474851-nanox-signs-distribution-agreement-with-digital-x-ray-imaging-to-expand-nanox-arc-adoption-in-arkansas</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:10:00+00:00</news:publication_date>
        <news:title>Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/7a1764f8-84e3-4b28-ae23-9add5d57c378/small/nanox-logo-4-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905474794-veld-pharmaceuticals-gmbh-announces-collaboration-with-chiesi-farmaceutici-s-p-a-to-expand-access-to-rare-disease-therapies-across-africa</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/047cc83e-f777-4658-9d34-e499423ec123/small/logo-veld-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905474801-impact-biotech-presents-preliminary-data-from-phase-1-study-of-padeliporfin-vtp-in-la-pdac-at-sir-2026-and-provides-strategic-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>ImPact Biotech Presents Preliminary Data from Phase 1 Study of Padeliporfin VTP in LA-PDAC at SIR 2026 and Provides Strategic Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/68762066-1fff-4065-af45-d18da25273cd/small/impact-biotech-logo-final-resized-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905474927-geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905474962-pacira-presents-real-world-data-on-exparel-showing-lower-total-healthcare-costs-in-outpatient-total-hip-and-knee-arthroplasty-procedures</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905474978-brainsway-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ea01c8f7-39be-46d2-a8e0-bc05994f170e/small/brainsway-2021-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905474988-septerna-announces-initiation-of-phase-1-clinical-trial-of-sep-479-an-oral-small-molecule-pth1r-agonist-for-the-treatment-of-hypoparathyroidism</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8c635733-2794-456f-9bc4-3b53908acba9/small/septernalogo-black-10x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475004-favorable-results-of-ovarian-cancer-study-presented-at-annual-society-of-gynecological-care-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7e828ef4-6c8f-4c94-b376-4e3749530fba/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475007-stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c24fe8bd-9db6-4f42-8a52-06a4e1b673b5/small/stryker-logo2015-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475009-praxis-to-showcase-essential3-the-first-positive-phase-3-program-in-essential-tremor-at-aan-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475038-cvrx-reports-preliminary-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>CVRx Reports Preliminary First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475045-daraxonrasib-demonstrates-unprecedented-overall-survival-benefit-in-pivotal-phase-3-rasolute-302-clinical-trial-in-patients-with-metastatic-pancreatic</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475055-eupraxia-pharmaceuticals-to-present-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475064-akebia-therapeutics-announces-first-participants-dosed-in-phase-1-clinical-trial-of-akb-9090</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475065-catheter-precision-announces-accepted-publication-in-leading-european-medical-journal</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Catheter Precision Announces Accepted Publication in Leading European Medical Journal</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905474987-nervgen-pharma-to-participate-in-the-h-c-wainwright-hcw-home-series-and-the-2026-bloom-burton-co-healthcare-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:45:00+00:00</news:publication_date>
        <news:title>NervGen Pharma to Participate in the H.C. Wainwright &quot;HCW@Home&quot; Series and the 2026 Bloom Burton &amp; Co. Healthcare Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905475034-with-brain-scan-volume-momentum-accelerating-firefly-makes-history-by-building-the-world-s-first-known-200-000-standardized-eeg-erp-depository</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:45:00+00:00</news:publication_date>
        <news:title>With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cd317e6a-730f-4537-a096-9b724abb964e/small/firefly-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905470717-allogene-therapeutics-reports-interim-futility-analysis-from-pivotal-alpha3-trial-showing-58-3-mrd-clearance-with-cemacabtagene-ansegedleucel</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:30:00+00:00</news:publication_date>
        <news:title>Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905470753-vireo-growth-announces-california-retail-joint-venture-with-glass-house-brands</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:30:00+00:00</news:publication_date>
        <news:title>Vireo Growth Announces California Retail Joint Venture with Glass House Brands</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905470768-newly-published-u-s-expert-consensus-aligns-with-mediwound-s-strategy-for-chronic-wound-debridement</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:30:00+00:00</news:publication_date>
        <news:title>Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905470778-northstrive-biosciences-announces-u-s-arrival-of-el-32-working-cell-bank-and-initiation-of-manufacturing-optimization-for-dual-myostatin-assets</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:30:00+00:00</news:publication_date>
        <news:title>NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b1dabc1a-ea7b-49d8-a9cd-406fd48dd65b/small/logo-color-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905470800-palvella-therapeutics-appoints-john-d-doux-m-d-m-b-a-dermatologist-and-recognized-leader-in-rare-skin-diseases-to-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:30:00+00:00</news:publication_date>
        <news:title>Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905470793-gelatide-drops-investigated-2026-report-what-consumers-should-verify-before-buying</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:23:50+00:00</news:publication_date>
        <news:title>Gelatide Drops Investigated (2026 Report) What Consumers Should Verify Before Buying</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/984a2986-fdd3-4fe6-80f2-312f9d1cbc94/image2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905467090-from-milestone-to-momentum-kraig-biocraft-leadership-travels-to-south-east-asia-following-record-setting-1-3-metric-ton-recombinant-spider-silk</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:05:00+00:00</news:publication_date>
        <news:title>From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905466754-oxb-launches-fast-track-offering-for-aav-and-lentiviral-vector-platforms-accelerating-viral-vector-development-and-manufacture</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/3e905c0a-b28c-4981-ac57-745647779ad9/small/oxb-new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905466795-eclipse-life-sciences-completes-enrollment-in-phase-2-study-evaluating-ec-104-for-diabetic-macular-edema-dme</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3ed9dd28-ed00-4f7d-b5b9-1180c2c99262/small/eclipse-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905466931-soleo-health-opens-new-ambulatory-infusion-center-in-louisville-kentucky</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>Soleo Health Opens New Ambulatory Infusion Center in Louisville, Kentucky</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b3c4bcdc-fa25-4f50-8b81-09f13e80a008/small/soleo-logo-1024-x-1024-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905466947-nrx-pharmaceuticals-nasdaq-nrxp-announces-appointment-of-glenn-tyson-as-the-company-s-first-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905466972-kymera-therapeutics-announces-u-s-fda-fast-track-designation-for-kt-621-a-first-in-class-oral-stat6-degrader-for-the-treatment-of-moderate-to</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905466973-spyre-announces-potential-best-in-class-spy001-part-a-induction-results-from-skyline-trial-in-moderate-to-severe-ulcerative-colitis-patients</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905466986-ocular-therapeutix-announces-additional-positive-week-52-data-from-landmark-sol-1-phase-3-trial-of-axpaxli-in-wet-amd</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905467081-imagenebio-announces-30-million-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>ImageneBio Announces $30 Million Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905466794-ani-pharmaceuticals-announces-the-launch-of-carbamazepine-extended-release-capsules</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:50:00+00:00</news:publication_date>
        <news:title>ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905467025-leanzene-gummies-examined-2026-consumer-focused-breakdown-of-ingredients-claims-label-transparency</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:47:40+00:00</news:publication_date>
        <news:title>Leanzene Gummies Examined: 2026 Consumer-Focused Breakdown of Ingredients, Claims &amp; Label Transparency</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/e7b8402e-d943-467a-8865-1fec7f5629cc/image2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905463063-regeneron-and-telix-announce-strategic-radiopharma-collaboration</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:30:00+00:00</news:publication_date>
        <news:title>Regeneron and Telix Announce Strategic Radiopharma Collaboration</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905463143-telix-and-regeneron-announce-strategic-radiopharma-collaboration</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:30:00+00:00</news:publication_date>
        <news:title>Telix and Regeneron Announce Strategic Radiopharma Collaboration</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905459654-prosomnus-receives-fda-class-ii-clearance-for-rpmo2-osa-device</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:00:00+00:00</news:publication_date>
        <news:title>ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA Device</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/333d9b0e-92b8-4e8b-ab32-6689f4113578/medium/prosomnus-rpmo2-osa-device-system.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905451931-smart-minimalism-supreme-efficiency-cuktech-15-charging-station-makes-its-debut-in-malaysia</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T08:40:54+00:00</news:publication_date>
        <news:title>Smart Minimalism, Supreme Efficiency: CUKTECH 15 Charging Station Makes Its Debut in Malaysia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3bf1f045-1f83-4d75-a8c5-1e9f3623347a/medium/image-1.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905452017-berikut-adalah-terjemahan-siaran-akhbar-tersebut-ke-dalam-bahasa-melayu-minimalisme-pintar-kecekapan-ulung-stesen-pengecasan-cuktech-15-membuat</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T08:40:54+00:00</news:publication_date>
        <news:title>Berikut adalah terjemahan siaran akhbar tersebut ke dalam Bahasa Melayu: Minimalisme Pintar, Kecekapan Ulung: Stesen Pengecasan CUKTECH 15 Membuat Kemunculan Sulung di Malaysia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3bf1f045-1f83-4d75-a8c5-1e9f3623347a/medium/image-1.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905445010-epitopea-strengthens-scientific-advisory-board-with-appointment-of-leading-authority-in-cancer-lisa-butterfield</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T08:00:00+00:00</news:publication_date>
        <news:title>Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e42e44d9-eec5-4ff3-a9ee-fab395efd2a8/small/epitopea-instagram-post-2-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905445013-epitopea-renforce-son-comit-consultatif-scientifique-avec-la-nomination-de-lisa-butterfield-figure-de-renom-dans-le-domaine-du-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T08:00:00+00:00</news:publication_date>
        <news:title>Epitopea renforce son comité consultatif scientifique avec la nomination de Lisa Butterfield, figure de renom dans le domaine du cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e42e44d9-eec5-4ff3-a9ee-fab395efd2a8/small/epitopea-instagram-post-2-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905445007-boehringer-ingelheim-introduces-lenzelta-a-new-vaccine-advancing-mastitis-prevention-in-dairy-cows</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T07:51:00+00:00</news:publication_date>
        <news:title>Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://wellnesswirekansas.com/article/905445021-rising-uk-dental-costs-and-nhs-access-crisis-drive-record-demand-for-treatment-in-t-rkiye-dentspa-leads-the-response</loc>
      <news:news>
        <news:publication>
          <news:name>Wellness Wire Kansas</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T07:30:00+00:00</news:publication_date>
        <news:title>Rising UK Dental Costs and NHS Access Crisis Drive Record Demand for Treatment in Türkiye — DentSpa Leads the Response</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/53fb3ee2-7271-4c5f-b8b5-f4e6db89cc89/small/dentspa-logo-blue-png.png</image:loc>
        </image:image>
    </url>
</urlset>
